Managing high-risk patients with hypertension: focus on the renin-angiotensin system

Area of Science:

• Cardiology
• Nephrology
• Pharmacology

Background:

• Hypertension treatment goals have shifted from solely lowering blood pressure to reducing patient morbidity and mortality.
• Achieving target blood pressure levels is crucial for improving patient outcomes.
• Hypertension with comorbidities like diabetes and left ventricular hypertrophy significantly elevates cardiovascular and renal risks.

Purpose of the Study:

• To review the evolving goals of hypertension management.
• To highlight the importance of achieving blood pressure control in high-risk patients.
• To emphasize the role of combination therapy and specific drug classes in managing complex hypertension.

Main Methods:

• Review of recent clinical trials and epidemiological studies.
• Analysis of data from large-scale hypertension treatment trials, including ALLHAT.
• Evaluation of the efficacy of different antihypertensive drug classes, particularly those targeting the renin-angiotensin system.

Main Results:

• Major cardiovascular and renal event reduction is linked to achieved blood pressure levels.
• Combination therapy is frequently necessary for effective hypertension management.
• Diuretics remain valuable, and agents blocking angiotensin II are crucial for high-risk populations.

Conclusions:

• Effective hypertension management requires a focus on reducing morbidity and mortality.
• Combination drug therapy is often essential for achieving target blood pressure in high-risk individuals.
• Angiotensin II-blocking agents play a vital role in preventing cardiovascular and renal events in high-risk hypertensive patients.